d-alpha tocopherol has been researched along with ribavirin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, XG; Jiang, JD; Li, L; Li, Y; Liu, YB; Ma, SG; Qu, J; Yu, SS; Zhang, D; Zhang, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ascione, A; Caporaso, N; Carbone, A; Fogliano, V; Marmo, R; Morisco, F; Scarpati, S; Stingo, S; Vitaglione, P | 1 |
| Bajaj, JS; Daniel, J; Franco, J; Ho, S; Knox, JF; McKee, D; Peine, C; Saeian, K; Varma, RR | 1 |
| Hara, Y; Hino, K; Kawakami, T; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M | 1 |
| Furutani, T; Hara, Y; Hino, K; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M; Ren, F; Yamaguchi, Y; Yamashita, S; Yutoku, K | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K; Tsukamoto, I | 1 |
| Dansako, H; Ikeda, M; Kato, N; Kim, HS; Mori, K; Sato, A; Takeda, M; Ueda, Y; Wakita, T; Wataya, Y | 1 |
1 review(s) available for d-alpha tocopherol and ribavirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for d-alpha tocopherol and ribavirin
| Article | Year |
|---|---|
High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
Topics: Adult; Antioxidants; Antiviral Agents; Drug Therapy, Combination; Female; Hemolysis; Hepatitis C, Chronic; Humans; Male; Quality of Life; Ribavirin; Vitamin E | 2004 |
Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Vitamin E; Vitamins | 2006 |
Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
Topics: alpha-Tocopherol; Ascorbic Acid; Drug Therapy, Combination; Eicosapentaenoic Acid; Erythrocyte Membrane; Female; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Treatment Outcome | 2006 |
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Carnosine; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Flow Cytometry; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organometallic Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiobarbituric Acid Reactive Substances; Time Factors; Transaminases; Treatment Outcome; Vitamin E; Vitamins; Zinc; Zinc Compounds | 2007 |
5 other study(ies) available for d-alpha tocopherol and ribavirin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sesquiterpenes and alkaloids from the roots of Alangium chinense.
Topics: Alangiaceae; Alkaloids; Animals; Antiviral Agents; Chlorocebus aethiops; Crystallography, X-Ray; Drugs, Chinese Herbal; Enterovirus; Humans; Inhibitory Concentration 50; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Rats; Sesquiterpenes; Vero Cells | 2013 |
Tomato-based functional food as interferon adjuvant in HCV eradication therapy.
Topics: Antioxidants; Antiviral Agents; Biological Availability; Carotenoids; Drug Therapy, Combination; Female; Flavonoids; Hepatitis C, Chronic; Humans; Interferons; Male; Oxidative Stress; Ribavirin; Treatment Outcome; Vitamin E | 2004 |
Eicosapentaenoic acid supplementation for chronic hepatitis C patients during combination therapy of pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitamin E | 2008 |
New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.
Topics: Antimalarials; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Synergism; Genome, Viral; Genotype; Hepacivirus; Humans; Interferon-alpha; Ribavirin; RNA, Viral; Time Factors; Virus Replication; Vitamin E | 2013 |